Seasoned corporate executive with a strong background in clinical and basic science, and nearly two decades of broad strategic and operational leadership roles in clinical research and drug development in the pharmaceutical industry, including hematology, oncology, and immunology. Held executive leadership positions in small- and mid-sized biotechs as well as large pharma, leading to the development of multiple compounds and biologics from Phase I through Phase IV, and the successful approval and commercialization of four novel products. Has served as chief company spokesperson with regulatory authorities and multiple strategic partnerships, partnered effectively with internal and exter...